Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,040.00
(
-2.01%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
101.12
(
0.45%
)
Bitcoin
68,941.00
(
0.23%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 10403

Saturday, 06/21/2008 6:15:57 AM

Saturday, June 21, 2008 6:15:57 AM

Post# of 19309
Notes on Pharming Group, NV

[Updated for US phase-3 Rhucin data.]


#msg-30035067 Phase-3 Rhucin data (US)
#msg-22482530 Pharming seeks US Rhucin partner
#msg-22208171 Phase-3 Rhucin data (Europe)
#msg-27808107 EMEA rejects Rhucin re-examination

#msg-28598316 1Q08 financial results
#msg-28546713 Update from 2008 annual meeting
#msg-28738755 New program in “aging”

#msg-18949245 IP cross-license with GTC
#msg-27220955 Pharming licenses cattle IP from ACTC

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today